On Thursday, SunPower announced fourth-quarter losses of 51 cents per share which missed the analyst consensus estimate of losses of 24 cents by 112.5%. The company reported quarterly sales of $361.3 million, missing the analyst consensus estimate of $362.85 million and respresting a 27.35% decrease over sales of $497.31 million from the same period last year.
Children's Place stated in an SEC filing that it has received correspondence from Snowball Compounding Ltd. and parties related to Mithaq Capital notifying the company that they own approximately 54% of the company's outstanding shares and intend to nominate 11 persons to stand for election to The Children's Place's board of directors at the company's 2024 annual meeting of shareholders.
Crispr Therapeutics shares are trading higher Thursday after Wolfe Research analyst Andy Chen initiated coverage on Crispr Therapeutics with a Peer Perform rating. Crispr Therapeutics' shares have risen nearly 37% over the past month following the FDA approval of Casgevy (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 gene-edited cell therapy, for transfusion-dependent beta-thalassemia (TDT) in patients 12 years and older on Jan. 16.
Intuitive Machines said the IM-1 mission launched from Launch Complex 39A at NASA's Kennedy Space Center in Florida at 1:05 a.m. ET on Thursday. It reached its intended orbit approximately 48 minutes later and established first communication with the lander at 1:59 a.m. ET.